Flu News and Research

RSS

Ignoring CDC recommendations enhances fear and anger among employees

Companies worldwide are facing unprecedented challenges due to the COVID-19 pandemic, from modifying operations to keeping employees safe and informed. But not all businesses have followed the recommended safety protocols set by the Centers for Disease Control and Prevention.

16 Dec 2020

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance.

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Survey results of COVID-19 vaccine hesitancy suggest that people are less likely to get the COVID-19 vaccine than the number of people who got the flu shot.

16 Dec 2020

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.

16 Dec 2020

Using hypoxia adaptations in marine mammals to understand COVID-19

News-Medical talks to Terrie Williams about how the diving physiology that adapts marine mammals to hypoxia can improve our understanding of COVID-19.

16 Dec 2020

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month.

15 Dec 2020

Flavobac™ Cold & Flu Guard provides a natural barrier against bacteria and viruses

Flavobac Cold & Flu Guard, developed by leading preventative dentistry provider Oraldent, is a completely natural oral and nasal barrier against bacteria and viruses, including SARS-CoV-2 and influenza.

15 Dec 2020

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.

15 Dec 2020

EUROIMMUN receives CE mark for new PCR test to differentiate between COVID-19 and flu

EUROIMMUN today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of viruses.

From Revvity 15 Dec 2020

Pandemic backlash jeopardizes public health powers, leaders

A series examining how the U.S. public health front lines have been left understaffed and ill-prepared to save us from the coronavirus pandemic.

15 Dec 2020

Smart ring can be reliably used to detect the onset of fevers

Temperature data collected by wearable devices worn on the finger can be reliably used to detect the onset of fevers, a leading symptom of both COVID-19 and the flu, according to a team of researchers from the University of California San Diego, UC San Francisco and MIT Lincoln Lab.

14 Dec 2020

GlobalData: U.S. cannot wait on vaccines to fight COVID-19

Following the news that the US Food and Drug Administration (FDA) has recommended emergency approval for the Pfizer-BioNTech COVID-19 vaccine and that the US has reported its highest one-day COVID-19 death tally;

14 Dec 2020

Pre-existing immunity shapes a person's antibody response to influenza viruses

New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected.

11 Dec 2020